US Stock MarketDetailed Quotes
RNUGF RENEURON GROUP
- 0.001
- 0.0000.00%
15min DelayClose May 23 09:30 ET
40.02KMarket Cap-6P/E (TTM)
0.000High0.000Low0Volume0.001Open0.001Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)57.17MShares0.05152wk High0.01P/B40.02KFloat Cap0.00152wk Low--Dividend TTM57.17MShs Float0.051Historical High--Div YieldTTM0.00%Amplitude0.001Historical Low--Avg Price1Lot Size
About RENEURON GROUP Company
ReNeuron Group Plc engages in the development of novel cell-based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom.
Company Profile
SymbolRNUGF
Company NameRENEURON GROUP
Founded2005
CEOMr. Olav Hellebo
MarketPink Market
Employees34
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
AddressPencoed Business Park
CityPencoed
ProvinceBridgend
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCF35 5HY
Phone44-203-819-8400
Websitehttp://www.reneuron.com
Company Executives
- Name
- Position
- Salary
- Iain Gladstone Ross
- Executive Director,Chairman
- 430.00K
- Dr. Michael John Owen
- Non-Executive Director
- 48.00K
- Martin Charles Walton
- Non-Executive Director
- 50.00K
- Barbara Regina Staehelin
- Non-Executive Director,Senior Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg